Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Liver Diseases

  Free Subscription


Articles published in Transplantation

Retrieve available abstracts of 122 articles:
HTML format



Single Articles


    October 2021
  1. JAMAL M, AlMahmeed H, AlGhanem M, AlMatooq M, et al
    Organ Transplantation in Kuwait and the Recent Initiation of a Liver Program.
    Transplantation. 2021;105:2125-2127.
    PubMed    


  2. YOELI D, Choudhury RA, Nydam TL, Pomposelli JJ, et al
    The Surge in Deceased Liver Donors Due to the Opioid Epidemic: Is It Time to Split the Difference?
    Transplantation. 2021;105:2239-2244.
    PubMed     Abstract available


    September 2021
  3. LIU Y, Lei Z, Chai H, Xiang S, et al
    Thrombomodulin-mediated Inhibition of Neutrophil Extracellular Trap Formation Alleviates Hepatic Ischemia/Reperfusion Injury by Blocking TLR4 in Rats Subjected to Liver Transplantation.
    Transplantation. 2021 Sep 16. pii: 00007890-900000000-95154.
    PubMed     Abstract available


  4. SCHLEGEL A, Foley DP, Savier E, Flores Carvalho M, et al
    Recommendations for Donor and Recipient Selection and Risk Prediction: Working Group Report From the ILTS Consensus Conference in DCD Liver Transplantation.
    Transplantation. 2021;105:1892-1903.
    PubMed     Abstract available


    July 2021
  5. SOGBE M, Lopez-Guerra D, Blanco-Fernandez G, Sangro B, et al
    Durvalumab as a Successful Downstaging Therapy for Liver Transplantation in Hepatocellular Carcinoma: the Importance of a Wash-Out Period.
    Transplantation. 2021 Jul 19. pii: 00007890-900000000-95194.
    PubMed    


  6. PATRONO D, Zanierato M, Avolio AW, Romagnoli R, et al
    Different Timing of Cholangiocyte and Hepatocyte Damage in Liver Preservation: Time to Implement Donor Interventions and New Preservation Techniques to Prevent Ischemic-type Biliary Lesions.
    Transplantation. 2021;105:e77-e78.
    PubMed    


  7. MRZLJAK A, Mikulic D, Busic M, Vukovic J, et al
    Liver Transplantation in Croatia: "David Among Goliaths".
    Transplantation. 2021;105:1389-1391.
    PubMed    


  8. B N, J H, G L, A K, et al
    O-14: Portal Hypertensive Complications after Pediatric Combined Liver-intestine Transplantation from Late Vascular Compromise of Native Portacaval Shunt: Clinical Presentation and Management.
    Transplantation. 2021;105.
    PubMed    


    June 2021
  9. CENTONZE L, Lauterio A, De Carlis R, Ferla F, et al
    Successful Liver Transplantation From a Donation After Brain Death Donor With Cerebral Venous Sinus and Hepatic Veins Thrombosis Occurred After ChAdOx1 nCov-19 Vaccination.
    Transplantation. 2021 Jun 23. pii: 00007890-900000000-95222.
    PubMed    


  10. LIU XB, Liu H, Liu J, Cheung AKL, et al
    Cytomegalovirus Latency Exacerbated small-for-size Liver Graft Injury through Activation of CCL19/CCR7 in Hepatic Stellate Cells.
    Transplantation. 2021 Jun 2. doi: 10.1097/TP.0000000000003846.
    PubMed     Abstract available


  11. GORGEN A, Sapisochin G
    Re: Hepatobiliary Scintigraphy to Increase the Safety in Right Lobe Living Donor Liver Transplantation: Not Just a Matter of Age and Remnant Volume.
    Transplantation. 2021;105:e64.
    PubMed    


  12. SERENARI M, Ravaioli M, Cescon M
    Hepatobiliary Scintigraphy to Increase the Safety in Right Lobe Living Donor Liver Transplantation: Not Just a Matter of Age and Remnant Volume.
    Transplantation. 2021;105:e63.
    PubMed    


  13. PERI AM, Magro B, van den Bogaart L, Dalla Pria A, et al
    Successful Treatment of Suspected Donor-derived Human Herpesvirus-8 Infection in a Liver Transplant Patient With Coronavirus Disease-19.
    Transplantation. 2021;105:e65-e67.
    PubMed    


  14. CANNON RM, Goldberg DS, Eckhoff DE, Anderson DJ, et al
    Early Outcomes With the Liver-kidney Safety Net.
    Transplantation. 2021;105:1261-1272.
    PubMed     Abstract available


    April 2021
  15. BUSCEMI V, De Carlis R, Lauterio A, Camozzi ML, et al
    Liver Transplantation From a Donor With Noonan Syndrome: Caveat Emptor.
    Transplantation. 2021;105:e50-e51.
    PubMed    


  16. BONIFAZI F, Sica S, Angeletti A, Marktel S, et al
    Veno-occlusive Disease in HSCT Patients: Consensus-based Recommendations for Risk Assessment, Diagnosis, and Management by the GITMO Group.
    Transplantation. 2021;105:686-694.
    PubMed     Abstract available


    March 2021
  17. YAMADA M, Funaki T, Shoji K, Miyairi I, et al
    Do Not Delay: Safe Operation for Pediatric Living-donor Liver Transplantation Programs in the COVID-19 Era.
    Transplantation. 2021;105:e39-e40.
    PubMed    


  18. WEISS E, Giabicani M, Saner F
    Do Liver Transplantation Criteria Differ According to the Type of Donor and the Severity of the Recipient?
    Transplantation. 2021;105:e32.
    PubMed    


  19. XUE Y, Liu H, Yang XX, Pang L, et al
    Inhibition of Carnitine Palmitoyltransferase 1A Aggravates Fatty Liver Graft Injury via Promoting Mitochondrial Permeability Transition.
    Transplantation. 2021;105:550-560.
    PubMed     Abstract available


    February 2021
  20. HAN S, Cho J, Wi W, Lee KW, et al
    Sex difference in the tolerance of hepatic ischemia-reperfusion injury and hepatic estrogen receptor expression according to age and macrosteatosis in healthy living liver donors.
    Transplantation. 2021 Feb 22. doi: 10.1097/TP.0000000000003705.
    PubMed     Abstract available


  21. SHAKED O, Demetris J, Levitsky J, Feng S, et al
    Impact of Donor and Recipient Clinical Characteristics and Hepatic Histology on Steatosis/Fibrosis Following Liver Transplantation.
    Transplantation. 2021 Feb 8. doi: 10.1097/TP.0000000000003681.
    PubMed     Abstract available


    January 2021
  22. KING EA, Brennan DC
    The Science Is Only as Good as the Data: The Case of Fontan-associated Liver Disease.
    Transplantation. 2021;105:23-24.
    PubMed    


  23. KIM MH, Nguyen A, Lo M, Kumar SR, et al
    Big Data in Transplantation Practice-the Devil Is in the Detail-Fontan-associated Liver Disease.
    Transplantation. 2021;105:18-22.
    PubMed     Abstract available


    December 2020
  24. CULLARO G, Rubin J, Mehta N, Yao F, et al
    Sex-Based Disparities in Hepatocellular Carcinoma Recurrence After Liver Transplantation.
    Transplantation. 2020 Dec 14. doi: 10.1097/TP.0000000000003575.
    PubMed     Abstract available


  25. GOLDBERG DS, Vianna RM, Martin EF, Martin P, et al
    Simultaneous Liver Kidney Transplant in Elderly Patients With Chronic Kidney Disease: Is There an Appropriate Upper Age Cutoff?
    Transplantation. 2020;104:2538-2546.
    PubMed     Abstract available


  26. CARDINI B, Fodor M, Hermann M, Wieser V, et al
    Live Confocal Imaging as a Novel Tool to Assess Liver Quality: Insights From a Murine Model.
    Transplantation. 2020;104:2528-2537.
    PubMed     Abstract available


    November 2020
  27. KARVELLAS CJ, Francoz C, Weiss E
    Liver Transplantation in Acute-on-Chronic Liver Failure.
    Transplantation. 2020 Nov 17. doi: 10.1097/TP.0000000000003550.
    PubMed     Abstract available


  28. ZIOGAS IA, Giannis D, Economopoulos KP, Hayat MH, et al
    Liver Transplantation for Intrahepatic Cholangiocarcinoma: A Meta-analysis and Meta-regression of Survival Rates.
    Transplantation. 2020 Nov 13. doi: 10.1097/TP.0000000000003539.
    PubMed     Abstract available


    October 2020
  29. CARTIN-CEBA R, Burger C, Swanson K, Vargas H, et al
    Clinical Outcomes after Liver Transplantation in Patients with Portopulmonary Hypertension.
    Transplantation. 2020 Oct 12. doi: 10.1097/TP.0000000000003490.
    PubMed     Abstract available


  30. WALLACE D, Cowling TE, Walker K, Suddle A, et al
    The Impact of Performance Status on Length of Hospital Stay and Clinical Complications Following Liver Transplantation.
    Transplantation. 2020 Oct 8. doi: 10.1097/TP.0000000000003484.
    PubMed     Abstract available


  31. HESSHEIMER AJ, Fondevila C
    Posttransplantation HCC Surveillance: Impact on Outcome or Byproduct of Biology?
    Transplantation. 2020;104:1997-1998.
    PubMed    


  32. CAMPOS-VARELA I, Dodge JL, Berenguer M, Adam R, et al
    Temporal Trends and Outcomes in Liver Transplantation for Recipients With HIV Infection in Europe and United States.
    Transplantation. 2020;104:2078-2086.
    PubMed     Abstract available


    September 2020
  33. HSU YC, Yu IS, Tsai YF, Wu YM, et al
    A Pre-conditioning Strategy to Augment Retention and Engraftment Rate of Donor Cells during Hepatocyte Transplantation.
    Transplantation. 2020 Sep 22. doi: 10.1097/TP.0000000000003461.
    PubMed     Abstract available


  34. EL-DOMIATY N, Saliba F, Vibert E, Karam V, et al
    Early versus Late Hepatocellular Carcinoma Recurrence after Transplantation: Predictive Factors, Patterns and Long-term Outcome.
    Transplantation. 2020 Sep 1. doi: 10.1097/TP.0000000000003434.
    PubMed     Abstract available


    August 2020
  35. MANCUSO A
    Sorafenib for Hepatocellular Carcinoma Recurrence After Liver Transplant.
    Transplantation. 2020;104:e243.
    PubMed    


  36. INVERNIZZI F, Iavarone M
    The Authors' Reply.
    Transplantation. 2020;104:e244.
    PubMed    


  37. COUSIN VL, Rougemont AL, Rubbia-Brandt L, Wildhaber BE, et al
    Peripheral Donor-specific Antibodies Are Associated With Histology and Cellular Subtypes in Protocol Liver Biopsies of Pediatric Recipients.
    Transplantation. 2020;104:1633-1643.
    PubMed     Abstract available


  38. MOGUL DB, Perito ER, Wood N, Mazariegos GV, et al
    Impact of Acuity Circles on Outcomes for Pediatric Liver Transplant Candidates.
    Transplantation. 2020;104:1627-1632.
    PubMed     Abstract available


  39. LU YG, Pan ZY, Zhang S, Lu YF, et al
    Living Donor Liver Transplantation in Children: Perioperative Risk Factors and a Nomogram for Prediction of Survival.
    Transplantation. 2020;104:1619-1626.
    PubMed     Abstract available


  40. JACKSON KR, Bowring MG, Holscher C, Haugen CE, et al
    Outcomes After Declining a Steatotic Donor Liver for Liver Transplant Candidates in the United States.
    Transplantation. 2020;104:1612-1618.
    PubMed     Abstract available


  41. JACKSON KR, Motter JD, Haugen CE, Long JJ, et al
    Minimizing Risks of Liver Transplantation With Steatotic Donor Livers by Preferred Recipient Matching.
    Transplantation. 2020;104:1604-1611.
    PubMed     Abstract available


  42. LUNSFORD KE, Agopian VG, Yi SG, Nguyen DTM, et al
    Delayed Implantation of Pumped Kidneys Decreases Renal Allograft Futility in Combined Liver-Kidney Transplantation.
    Transplantation. 2020;104:1591-1603.
    PubMed     Abstract available


  43. CHADHA R, De Martin E, Kabacam G, Kirchner V, et al
    Proceedings of the 25th Annual Congress of the International Liver Transplantation Society.
    Transplantation. 2020;104:1560-1565.
    PubMed     Abstract available


    July 2020
  44. KAUR N, Emamaullee J, Lian T, Lo M, et al
    Impact of Morbid Obesity on Liver Transplant Candidacy and Outcomes: National and Regional Trends.
    Transplantation. 2020 Jul 31. pii: 00007890-900000000-95575.
    PubMed     Abstract available


  45. LEE SG, Jeng LB, Saliba F, Singh Soin A, et al
    Efficacy and Safety of Everolimus With Reduced Tacrolimus in Liver Transplant Recipients: 24-month Results From the Pooled Analysis of Two Randomized Controlled Trials.
    Transplantation. 2020 Jul 22. pii: 00007890-900000000-95581.
    PubMed     Abstract available


  46. DE MARTIN E, Sapisochin G
    Predicting Liver Transplant Patient Outcomes. Is a Validated Model Enough?
    Transplantation. 2020 Jul 13. doi: 10.1097/TP.0000000000003354.
    PubMed    


  47. MOLINARI M, Jorgensen D, Ayloo S, Dharmayan S, et al
    Preoperative Stratification of Liver Transplant Recipients: Validation of the LTRS.
    Transplantation. 2020 Jul 13. doi: 10.1097/TP.0000000000003353.
    PubMed     Abstract available


  48. ABU RMILAH A, Fencl R, Watt K, Krowka M, et al
    Association of alpha 1 Antitrypsin Phenotype and Development of Advanced Liver Disease and Pulmonary Complications Before and After Liver Transplantation.
    Transplantation. 2020 Jul 6. doi: 10.1097/TP.0000000000003390.
    PubMed     Abstract available


  49. OSWARI H, Rahayatri TH, Soedibyo S
    Pediatric Living Donor Liver Transplant in Indonesia's National Referral Hospital.
    Transplantation. 2020;104:1305-1307.
    PubMed    


  50. HEIMBACH JK, Taner T
    To Thine Own Self Be True.
    Transplantation. 2020;104:1326-1327.
    PubMed    


  51. MAZUMDER NR, Atiemo K, Daud A, Kho A, et al
    Patients With Persistently Low MELD-Na Scores Continue to Be at Risk of Liver-related Death.
    Transplantation. 2020;104:1413-1418.
    PubMed     Abstract available


    June 2020
  52. HONG SK, Yi NJ, Cho JH, Lee JM, et al
    Parietal Peritoneum as a Novel Substitute for Middle Hepatic Vein Reconstruction During Living Donor Liver Transplantation.
    Transplantation. 2020 Jun 15. doi: 10.1097/TP.0000000000003349.
    PubMed     Abstract available


  53. WEISS E, Saner F, Asrani SK, Biancofiore G, et al
    When Is a Critically Ill Cirrhotic Patient Too Sick to Transplant? Development of Consensus Criteria by a Multidisciplinary Panel of 35 International Experts.
    Transplantation. 2020 Jun 15. doi: 10.1097/TP.0000000000003364.
    PubMed     Abstract available


  54. SIMPSON MA
    In France, Socioeconomic Status does not Affect Outcomes for Liver Transplantation for Hepatocellular Carcinoma: Encouraging Results but -- We need the Rest of the Story.
    Transplantation. 2020 Jun 9. doi: 10.1097/TP.0000000000003341.
    PubMed    


  55. MENAHEM B, Dejardin O, Alves A, Launay L, et al
    Socioeconomic Deprivation Does Not Impact Liver Transplantation Outcome for HCC: A Survival Analysis From a National Database.
    Transplantation. 2020 Jun 9. doi: 10.1097/TP.0000000000003340.
    PubMed     Abstract available


  56. SAPISOCHIN G, Hibi T, Ghobrial M, Man K, et al
    The ILTS Consensus Conference on Transplant Oncology: Setting the Stage.
    Transplantation. 2020;104:1119-1120.
    PubMed    


    May 2020
  57. BRAUN HJ, Dodge JL, Grab JD, Schwab ME, et al
    Live Donor Liver Transplantation in the United States: Impact of Share 35 on Live Donor Utilization.
    Transplantation. 2020 May 18. doi: 10.1097/TP.0000000000003318.
    PubMed     Abstract available


  58. KOSHY AN, Farouque O, Cailes B, Ko J, et al
    Prediction of Perioperative Cardiovascular Events in Liver Transplantation.
    Transplantation. 2020 May 11. doi: 10.1097/TP.0000000000003306.
    PubMed     Abstract available


  59. KUSAKABE J, Hata K, Tamaki I, Tajima T, et al
    Complement 5 Inhibition Ameliorates Hepatic Ischemia/reperfusion Injury in Mice, Dominantly via the C5a-mediated Cascade.
    Transplantation. 2020 May 5. doi: 10.1097/TP.0000000000003302.
    PubMed     Abstract available


    April 2020
  60. RODRIGUEZ-PERALVAREZ M, Gomez-Bravo MA, Sanchez-Antolin G, De la Rosa G, et al
    Expanding Indications of Liver Transplantation in Spain: Consensus Statement and Recommendations by the Spanish Society of Liver Transplantation.
    Transplantation. 2020 Apr 27. doi: 10.1097/TP.0000000000003281.
    PubMed     Abstract available


  61. AMIN A, Molina A, Quach L, Ito T, et al
    Liver Transplantation in Patients with Pretransplant Aspergillus Colonization: Is It Safe To Proceed?
    Transplantation. 2020 Apr 13. doi: 10.1097/TP.0000000000003276.
    PubMed     Abstract available


  62. LERUT J, Lai Q
    Red Blood Cells' Prestorage Leukoreduction and Reduced Risk of Posttransplant Hepatocellular Cancer Recurrence: Another Piece of the Tumor-immune System Puzzle?
    Transplantation. 2020 Apr 6. doi: 10.1097/TP.0000000000003266.
    PubMed    


  63. KWON JH, Han S, Jang JS, Lee KW, et al
    Decrease in the Risk of Post-Transplant Hepatocellular Carcinoma Recurrence After the Conversion to Prestorage Leukoreduction for Transfused Red Blood Cells.
    Transplantation. 2020 Apr 6. doi: 10.1097/TP.0000000000003265.
    PubMed     Abstract available


  64. RHU J, Kim JM, Choi GS, Kwon CHD, et al
    The Authors' Reply: Anatomical and Extra-Anatomical Hepatic Artery Reconstruction During Living Donor Liver Transplantation: Is It Reasonable to Classify This Way?
    Transplantation. 2020;104:e112-e113.
    PubMed    


  65. KURAMITSU K, Fukumoto T, Egawa H, Ohdan H, et al
    A Multicenter Japanese Survey Assessing the Long-term Outcomes of Liver Retransplantation Using Living Donor Grafts.
    Transplantation. 2020;104:754-761.
    PubMed     Abstract available


    March 2020
  66. SADD CJ, Osman F, Li Z, Chybowski A, et al
    Long-term Outcomes and Survival in Moderate-Severe Portopulmonary Hypertension After Liver Transplant.
    Transplantation. 2020 Mar 30. doi: 10.1097/TP.0000000000003248.
    PubMed     Abstract available


  67. CAILES B, Koshy AN, Gow P, Weinberg L, et al
    Inducible Left Ventricular Outflow Tract Obstruction in Patients Undergoing Liver Transplantation: Prevalence, Predictors and Association With Cardiovascular Events.
    Transplantation. 2020 Mar 27. doi: 10.1097/TP.0000000000003245.
    PubMed     Abstract available


  68. BERENGUER M, Burra P, Ghobrial M, Hibi T, et al
    Posttransplant management of recipients undergoing liver transplantation for hepatocellular carcinoma. Working Group Report from the ILTS Transplant Oncology Consensus Conference.
    Transplantation. 2020 Mar 23. doi: 10.1097/TP.0000000000003196.
    PubMed     Abstract available


  69. HIBI T, Rela M, Eason J, Line PD, et al
    Liver Transplantation for Colorectal and Neuroendocrine Liver Metastases and Hepatoblastoma. Working Group Report from the ILTS Transplant Oncology Consensus Conference.
    Transplantation. 2020 Mar 23. doi: 10.1097/TP.0000000000003118.
    PubMed     Abstract available


  70. MEHTA N, Bhangui P, Yao FY, Mazzaferro V, et al
    Liver Transplantation for Hepatocellular Carcinoma. Working Group Report from the ILTS Transplant Oncology Consensus Conference.
    Transplantation. 2020 Mar 23. doi: 10.1097/TP.0000000000003174.
    PubMed    


  71. SAPISOCHIN G, Javle M, Lerut J, Ohtsuka M, et al
    Liver Transplantation for Cholangiocarcinoma and Mixed Hepatocellular-cholangiocarcinoma. Working Group Report from the ILTS Transplant Oncology Consensus Conference.
    Transplantation. 2020 Mar 23. doi: 10.1097/TP.0000000000003212.
    PubMed     Abstract available


  72. RIZZARI MD, Safwan M, Sobolic M, Kitajima T, et al
    The Impact of Portal Vein Thrombosis on Liver Transplant Outcomes: Does Grade or Flow Rate Matter?
    Transplantation. 2020 Mar 18. doi: 10.1097/TP.0000000000003235.
    PubMed     Abstract available


  73. MAURO E, Crespo G, Martinez-Garmendia A, Gutierrez-Acevedo MN, et al
    Cystatin C and Sarcopenia Predict Acute on Chronic Liver Failure Development and Mortality in Patients on the Liver Transplant Waiting List.
    Transplantation. 2020 Mar 6. doi: 10.1097/TP.0000000000003222.
    PubMed     Abstract available


  74. NORDSTROM J, Lundgren M, Jorns C, Fischler B, et al
    First European Case of Simultaneous Liver and Pancreas Transplantation as Treatment of Wolcott-Rallison Syndrome in a Small Child.
    Transplantation. 2020;104:522-525.
    PubMed     Abstract available


    February 2020
  75. CRON DC, Tincopa MA, Lee JS, Waljee AK, et al
    Prevalence and patterns of opioid use before and after liver transplantation.
    Transplantation. 2020 Feb 4. doi: 10.1097/TP.0000000000003155.
    PubMed     Abstract available


  76. CONGLY SE, Brownfield KA
    Distinguishing Between Sex and Gender Is Critical for Research in Transplantation.
    Transplantation. 2020;104:e57.
    PubMed    


  77. MCELROY L, Likhitsup A, Sabeed N, Hassan A, et al
    Re: Distinguishing Between Sex and Gender Is Critical for Research in Transplantation.
    Transplantation. 2020;104:e58.
    PubMed    


  78. MAZUMDER NR, Atiemo K, Kappus M, Cullaro G, et al
    A Comprehensive Review of Outcome Predictors in Low MELD Patients.
    Transplantation. 2020;104:242-250.
    PubMed     Abstract available


  79. BABABEKOV YJ, Hung YC, Chang DC, Rickert CG, et al
    Do Social Determinants Define "Too Sick" to Transplant in Patients With End-stage Liver Disease?
    Transplantation. 2020;104:280-284.
    PubMed     Abstract available


  80. BHANGUI P, Sah J, Choudhary N, Gautam D, et al
    Safe Use of Right Lobe Live Donor Livers With up to 20% Macrovesicular Steatosis Without Compromising Donor Safety and Recipient Outcome.
    Transplantation. 2020;104:308-316.
    PubMed     Abstract available


    January 2020
  81. LEE DD, Sapisochin G, Mehta N, Gorgen A, et al
    Surveillance for HCC after Liver Transplantation: Increased monitoring may yield aggressive treatment options and improved postrecurrence survival.
    Transplantation. 2020 Jan 13. doi: 10.1097/TP.0000000000003117.
    PubMed     Abstract available


    November 2019
  82. TANER T, Martins PN, Ling Q, Ng KT, et al
    What Is Hot and New in Basic and Translational Science in Liver Transplantation in 2019? Report of the Basic and Translational Research Committee of the International Liver Transplantation Society.
    Transplantation. 2019 Nov 20. doi: 10.1097/TP.0000000000003058.
    PubMed     Abstract available


    October 2019
  83. CAUCHY F, Vibert E, Cherqui D, Perdigao F, et al
    Liver retransplantation associated with kidney transplantation for end stage liver graft disease and renal insufficiency: a morbid procedure on a unique subgroup of patients.
    Transplantation. 2019 Oct 23. doi: 10.1097/TP.0000000000003035.
    PubMed     Abstract available


  84. PETROWSKY H
    Avoiding dual graft loss in simultaneous liver retransplantation and primary kidney transplantation.
    Transplantation. 2019 Oct 22. doi: 10.1097/TP.0000000000003036.
    PubMed    


  85. VERNA EC, Connelly C, Dove LM, Adem P, et al
    Center-Related Bias in MELD Scores Within a Liver Transplant UNOS Region: A Call for Standardization.
    Transplantation. 2019 Oct 22. doi: 10.1097/TP.0000000000003031.
    PubMed     Abstract available


  86. CARRIER FM, Chasse M, Sylvestre MP, Girard M, et al
    Effects of intraoperative fluid balance during liver transplantation on postoperative acute kidney injury: an observational cohort study.
    Transplantation. 2019 Oct 21. doi: 10.1097/TP.0000000000002998.
    PubMed     Abstract available


    September 2019
  87. NORTHUP PG, Intagliata NM, Davis JPE, Argo CK, et al
    Macrosteatotic Allografts and Obese Recipients Have Nearly Equal Negative Impact on Liver Transplant Survival.
    Transplantation. 2019 Sep 30. doi: 10.1097/TP.0000000000002990.
    PubMed     Abstract available


  88. DAGAN A, Choudhury RA, Yaffe H, Yoeli D, et al
    Offspring vs. Non Offspring to Parent Living Donor Liver Transplantation: Does Donor Relationship Matter?
    Transplantation. 2019 Sep 19. doi: 10.1097/TP.0000000000002977.
    PubMed     Abstract available


  89. BROWN S, Savva Y, Barth R, LaMattina J, et al
    Multiple regional listing increases liver transplant rates for those with MELD score less than 15.
    Transplantation. 2019 Sep 18. doi: 10.1097/TP.0000000000002965.
    PubMed     Abstract available


  90. SANDAL S, Chen T, Cantarovich M
    The Challenges with the Cardiac Evaluation of Liver and Kidney Transplant Candidates.
    Transplantation. 2019 Sep 3. doi: 10.1097/TP.0000000000002951.
    PubMed     Abstract available


    August 2019
  91. WU DA, Robb ML, Forsythe JLR, Bradley C, et al
    Recipient Comorbidity and Survival Outcomes after Kidney Transplantation: a UK-wide Prospective Cohort Study.
    Transplantation. 2019 Aug 19. doi: 10.1097/TP.0000000000002931.
    PubMed     Abstract available


  92. WEEKS SR, Luo X, Haugen CE, Ottmann SE, et al
    Delayed graft function in simultaneous liver kidney transplantation.
    Transplantation. 2019 Aug 8. doi: 10.1097/TP.0000000000002908.
    PubMed     Abstract available


    July 2019
  93. MIKOVA I, Neroldova M, Hubacek JA, Dlouha D, et al
    DONOR PNPLA3 AND TM6SF2 VARIANT ALLELES CONFER ADDITIVE RISKS FOR GRAFT STEATOSIS AFTER LIVER TRANSPLANTATION.
    Transplantation. 2019 Jul 26. doi: 10.1097/TP.0000000000002876.
    PubMed     Abstract available


  94. SAKAMOTO S, Uchida H, Takeuchi I, Irie R, et al
    Sequential deceased donor intestine transplantation followed by living donor liver transplantation, also known as "hybrid intestine-liver transplantation".
    Transplantation. 2019 Jul 22. doi: 10.1097/TP.0000000000002883.
    PubMed    


  95. VEROLET CM, Pittet LF, Wildhaber BE, McLin VA, et al
    Long-term seroprotection of varicella-zoster immunization in pediatric liver transplant recipients.
    Transplantation. 2019 Jul 15. doi: 10.1097/TP.0000000000002866.
    PubMed     Abstract available


  96. ALVAREZ-MERCADO AI, Negrete-Sanchez E, Gulfo J, Avalos de Leon CG, et al
    EGF-GH Axis in Rat Steatotic and Non-steatotic Liver Transplantation From Brain-dead Donors.
    Transplantation. 2019;103:1349-1359.
    PubMed     Abstract available


    June 2019
  97. XIE H, Zhang L, Guo D, Yang Z, et al
    Protein Profiles of Pretransplant Grafts Predict Early Allograft Dysfunction After Liver Transplantation From Donation After Circulatory Death.
    Transplantation. 2019 Jun 25. doi: 10.1097/TP.0000000000002787.
    PubMed     Abstract available


  98. BECKMANN S, Drent G, Ruppar T, Nikolic N, et al
    Body weight parameters are related to morbidity and mortality after liver transplantation - A systematic review and meta-analysis.
    Transplantation. 2019 Jun 24. doi: 10.1097/TP.0000000000002811.
    PubMed     Abstract available


  99. MOLINARI M, Ayloo S, Tsung A, Jorgensen D, et al
    Prediction of Perioperative Mortality of Cadaveric Liver Transplant Recipients during their evaluations.
    Transplantation. 2019 Jun 24. doi: 10.1097/TP.0000000000002810.
    PubMed     Abstract available


  100. MCELROY LM, Likhitsup A, Winder GS, Saeed N, et al
    Gender Disparities in Patients with Alcoholic Liver Disease Evaluated for Liver Transplantation.
    Transplantation. 2019 Jun 24. doi: 10.1097/TP.0000000000002843.
    PubMed     Abstract available


  101. SCHIEFER J, Faybik P, Koch S, Tudor B, et al
    Glycocalyx damage within human liver grafts correlates with graft injury and postoperative graft function after orthotopic liver transplantation.
    Transplantation. 2019 Jun 24. doi: 10.1097/TP.0000000000002838.
    PubMed     Abstract available


    May 2019
  102. RODRIGUEZ-PERALVAREZ M, Guerrero M, De Luca L, Gros B, et al
    Area under trough concentrations of tacrolimus as a predictor of progressive renal impairment after liver transplantation.
    Transplantation. 2019 May 15. doi: 10.1097/TP.0000000000002760.
    PubMed     Abstract available


  103. MELLINGER JL
    Living Donor Liver Transplant in Alcohol-related Liver Disease: An Option Whose Time has Come.
    Transplantation. 2019 May 15. doi: 10.1097/TP.0000000000002784.
    PubMed    


  104. BRAUN HJ, Dodge JL, Grab JD, Syed SM, et al
    Living Donor Liver Transplant for Alcoholic Liver Disease: Data from the Adult to Adult Living Donor Liver Transplantation Study (A2ALL).
    Transplantation. 2019 May 15. doi: 10.1097/TP.0000000000002783.
    PubMed     Abstract available


  105. CHENG XS, Goldhaber-Fiebert J, Tan JC, Chertow GM, et al
    Defining a willingness-to-transplant threshold in an era of organ scarcity: Simultaneous liver-kidney transplant as a case example.
    Transplantation. 2019 May 15. doi: 10.1097/TP.0000000000002788.
    PubMed     Abstract available


    April 2019
  106. KAMAL L, Yu JW, Reichman TW, Kang L, et al
    Impact of Induction Immunosuppression strategies in Simultaneous Liver Kidney Transplantation.
    Transplantation. 2019 Apr 22. doi: 10.1097/TP.0000000000002768.
    PubMed     Abstract available


  107. ARAVINTHAN AD, Fateen W, Doyle AC, Venkatachalapathy SV, et al
    The impact of preexisting and posttransplant diabetes mellitus on outcomes following liver transplantation.
    Transplantation. 2019 Apr 10. doi: 10.1097/TP.0000000000002757.
    PubMed     Abstract available


  108. KUO SZ, Ahmad M, Dunn MA, Montano-Loza AJ, et al
    Sarcopenia Predicts Posttransplant Mortality in Acutely Ill Men Undergoing Urgent Evaluation and Liver Transplantation.
    Transplantation. 2019 Apr 8. doi: 10.1097/TP.0000000000002741.
    PubMed     Abstract available


  109. KAPPI T, Rabe H, Lingblom C, Hesselmar B, et al
    High frequency of concomitant food allergy development and autoantibody formation in children who have undergone liver transplantation.
    Transplantation. 2019 Apr 8. doi: 10.1097/TP.0000000000002751.
    PubMed     Abstract available


  110. SIDDIQUI MB, Patel S, Arshad T, Lee E, et al
    The Relationship Between Hypoadiponectinemia and Cardiovascular Events in Liver Transplant Recipients.
    Transplantation. 2019 Apr 1. doi: 10.1097/TP.0000000000002714.
    PubMed     Abstract available


    March 2019
  111. TAPPER EB, Wexler R, Goldman E, Volk M, et al
    Constitutional Challenges to Liver Transplant Policy.
    Transplantation. 2019 Mar 5. doi: 10.1097/TP.0000000000002703.
    PubMed     Abstract available


  112. MALIK AK, Masson S, Allen E, Akyol M, et al
    Impact of regional organ sharing and allocation in the UK Northern Liver Alliance on waiting time to liver transplantation and waitlist survival.
    Transplantation. 2019 Mar 1. doi: 10.1097/TP.0000000000002687.
    PubMed     Abstract available


    February 2019
  113. BOWRING MG, Zhou S, Chow EKH, Massie AB, et al
    Geographic disparity in deceased-donor liver transplant rates following Share 35.
    Transplantation. 2019 Feb 19. doi: 10.1097/TP.0000000000002643.
    PubMed     Abstract available


  114. VAN DER VEER MAA, Nangrahary N, Hesselink DA, Erler NS, et al
    High Intra-Patient Variability in Tacrolimus Exposure Is Not Associated with Immune-Mediated Graft Injury after Liver Transplantation.
    Transplantation. 2019 Feb 19. doi: 10.1097/TP.0000000000002680.
    PubMed     Abstract available


  115. QU W, Wei L, Zhu ZJ, Sun LY, et al
    Considerations for Use of Domino Cross-Auxiliary Liver Transplantation in Metabolic Liver Diseases: A review of Case Studies.
    Transplantation. 2019 Feb 18. doi: 10.1097/TP.0000000000002602.
    PubMed     Abstract available


  116. SAFWAN M, Nwagu U, Collins K, Abouljoud M, et al
    Should all Status 1A patients be prioritized over high MELD patients? Concept of Risk Stratification in Extremely Ill Liver Transplant Recipients.
    Transplantation. 2019 Feb 4. doi: 10.1097/TP.0000000000002651.
    PubMed     Abstract available


    January 2019
  117. CHANG SH, Wang M, Liu X, Alhamad T, et al
    Racial/ethnic disparities in access and outcomes of simultaneous liver-kidney transplant among liver transplant candidates with renal dysfunction in the United States.
    Transplantation. 2019 Jan 30. doi: 10.1097/TP.0000000000002574.
    PubMed     Abstract available


    November 2018
  118. DE BOER J, Braat A, Putter H, de Vries E, et al
    Outcome of liver transplant patients with high urgent priority. Are we doing the right thing?
    Transplantation. 2018 Nov 21. doi: 10.1097/TP.0000000000002526.
    PubMed     Abstract available


  119. MUSTIAN MN, Shelton BA, MacLennan PA, Reed RD, et al
    Ethnic and Age Disparities in Outcomes among Liver Transplant Waitlist Candidates.
    Transplantation. 2018 Nov 9. doi: 10.1097/TP.0000000000002523.
    PubMed     Abstract available


    October 2018
  120. SINGH A, Fritze D, Mansouri M, Lopez R, et al
    Characteristics and Outcomes of Liver Transplantation for Primary Biliary Cholangitis (PBC) in Young patients: Analysis of the United Network for Organ Sharing Database.
    Transplantation. 2018 Oct 30. doi: 10.1097/TP.0000000000002501.
    PubMed     Abstract available


  121. DOSHI SD, Wood L, Abt PL, Olthoff KM, et al
    Outcomes of living donor liver transplantation using grafts heterozygous for alpha-1 antitrypsin gene mutations.
    Transplantation. 2018 Oct 16. doi: 10.1097/TP.0000000000002493.
    PubMed     Abstract available


  122. IYER VN, Saberi B, Heimbach JK, Larson JJ, et al
    Liver Transplantation Trends and Outcomes for Hereditary Hemorrhagic Telangiectasia In the United States.
    Transplantation. 2018 Oct 16. doi: 10.1097/TP.0000000000002491.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Liver Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: